212 related articles for article (PubMed ID: 19762261)
1. Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease.
Méndez-Samperio P
Int J Infect Dis; 2010 May; 14(5):e366-71. PubMed ID: 19762261
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
4. Human host response to Mycobacterium tuberculosis.
Rom WN; Schluger N; Law K; Condos R; Zhang Y; Weiden M; Harkin T; Tchou-Wong KM
Schweiz Med Wochenschr; 1995 Nov; 125(45):2178-85. PubMed ID: 8525336
[TBL] [Abstract][Full Text] [Related]
5. [Up-to-date understanding of tuberculosis immunity].
Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
[TBL] [Abstract][Full Text] [Related]
6. Functions of T-cell subsets and cytokines in mycobacterial infections.
Munk ME; Emoto M
Eur Respir J Suppl; 1995 Sep; 20():668s-675s. PubMed ID: 8590567
[TBL] [Abstract][Full Text] [Related]
7. Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels.
Mutis T; Cornelisse YE; Ottenhoff TH
Eur J Immunol; 1993 Sep; 23(9):2189-95. PubMed ID: 8103743
[TBL] [Abstract][Full Text] [Related]
8. [Plasmid encoding human IL-12 improve protective efficacy of Mtb8.4 gene vaccine with signal sequence against infection of Mycobacterium Tuberculosis].
Li H; Li R; Zhong S; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):291-4. PubMed ID: 17428378
[TBL] [Abstract][Full Text] [Related]
9. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge.
Khader SA; Bell GK; Pearl JE; Fountain JJ; Rangel-Moreno J; Cilley GE; Shen F; Eaton SM; Gaffen SL; Swain SL; Locksley RM; Haynes L; Randall TD; Cooper AM
Nat Immunol; 2007 Apr; 8(4):369-77. PubMed ID: 17351619
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.
Cooper AM; Roberts AD; Rhoades ER; Callahan JE; Getzy DM; Orme IM
Immunology; 1995 Mar; 84(3):423-32. PubMed ID: 7751026
[TBL] [Abstract][Full Text] [Related]
13. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
Kim SH; Cho D; Kim TS
Vaccine; 2006 Apr; 24(16):3365-73. PubMed ID: 16481075
[TBL] [Abstract][Full Text] [Related]
15. Control of human host immunity to mycobacteria.
Ottenhoff TH; Verreck FA; Hoeve MA; van de Vosse E
Tuberculosis (Edinb); 2005; 85(1-2):53-64. PubMed ID: 15687028
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. [Immunology of tuberculosis and cytokines].
Tsuyuguchi I
Kekkaku; 1995 May; 70(5):335-46. PubMed ID: 7783394
[TBL] [Abstract][Full Text] [Related]
19. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
Hovav AH; Bercovier H
Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
[TBL] [Abstract][Full Text] [Related]
20. [Protective immunity against Mycobacterium tuberculosis].
Kawamura I
Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
